Vanda Pharmaceuticals to Participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day

WASHINGTON, Feb. 1, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of novel therapies addressing high unmet medical needs, today announced that members of its management team will participate in the Canaccord Genuity Rare Disease, Biopharma One-on-One Day on Tuesday, February 2, 2016 in New York City.

For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Senior Vice President and Chief Financial Officer

Vanda Pharmaceuticals Inc.

SOURCE Vanda Pharmaceuticals Inc.

more press release views with